Stock Events

Stock Events

Abbvie 

$256.46
33343
-$3.75-1.44% Friday 20:03
+$4.26+1.66%Friday 23:59After hours

Statistics

Day High
258.91
Day Low
255.61
52W High
267.47
52W Low
190.75
Volume
4,701,126
Avg. Volume
6,404,939
Mkt Cap
453.19B
P/E Ratio
122.21
Dividend Yield
2.7%
Dividend
6.92

Upcoming

Dividends

2.7%Dividend Yield
Aug 26
$1.73
May 26
$1.73
Feb 26
$1.73
Nov 25
$1.64
Aug 25
$1.64
10Y Growth
11.89%
5Y Growth
6.1%
3Y Growth
5.3%
1Y Growth
5.56%

Earnings

23OctExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
1.77
2.46
3.16
3.86
Expected EPS
3.861902
Actual EPS
N/A

Financials

6.91%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
61.16BRevenue
4.23BNet Income

Analyst Ratings

282.80Average Price Target
The highest estimate is 300.00.
From 15 ratings within the last 6 months. This is not an investment recommendation.
Buy
87%
Hold
13%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ABBV. It's not an investment recommendation.
Realty Income
9958
O
Microsoft
8483
MSFT
Apple
8380
AAPL
Coca-Cola
7263
KO

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson competes with AbbVie in the pharmaceutical sector, particularly in immunology and oncology.
Pfizer
PFE
Mkt Cap159.36B
Pfizer competes across several therapeutic areas including immunology and oncology, similar to AbbVie's portfolio.
Merck
MRK
Mkt Cap366B
Merck is a key competitor in the pharmaceutical industry, especially in the oncology market where both companies have significant investments.
GSK
GSK
Mkt Cap101.78B
GlaxoSmithKline competes with AbbVie in the pharmaceutical and healthcare sector, with overlapping interests in immunology.
Novartis
NVS
Mkt Cap292.35B
Novartis competes with AbbVie in multiple areas including immunology and neuroscience.
Bristol-Myers Squibb
BMY
Mkt Cap136B
Bristol Myers Squibb competes in the biopharmaceutical sector, particularly in oncology and cardiovascular diseases, areas where AbbVie is also active.
AMGEN
AMGN
Mkt Cap233.78B
Amgen competes with AbbVie in the biotech sector, particularly in treatments for inflammatory diseases.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG competes with AbbVie in the oncology and immunology sectors, with a strong focus on biopharmaceuticals.
Sanofi
SNY
Mkt Cap107.39B
Sanofi competes with AbbVie in areas such as immunology, with both companies developing treatments for various autoimmune diseases.
Astrazeneca
AZN
Mkt Cap252.33B
AstraZeneca competes with AbbVie, particularly in the oncology sector, where both companies are seeking to expand their portfolios.

About

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
Show more...
CEO
Robert A. Michael
Employees
57000
Country
United States
ISIN
US00287Y1091
WKN
000A1J84E

Listings

XNYS
US
ABBV
F
DE
4AB.F
STU
DE
4AB.STU
BK
TH
ABBV19.BK

0 Comments

Share your thoughts

FAQ

What is Abbvie stock price today?▼
The current price of ABBV is $256.46 USD — it has decreased by -1.44% in the past 24 hours. Watch Abbvie stock price performance more closely on the chart.
What is Abbvie stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNYS exchange Abbvie stocks are traded under the ticker ABBV.
Is Abbvie stock price growing?▼
ABBV stock has risen by +0.38% compared to the previous week, the month change is a +4.17% rise, over the last year Abbvie has showed a +20.65% increase.
What is Abbvie market cap?▼
Today Abbvie has the market capitalization of 453.19B
When is the next Abbvie earnings date?▼
Abbvie is going to release the next earnings report on October 23, 2026.
What were Abbvie earnings last quarter?▼
ABBV earnings for the last quarter are 3.65 USD per share, whereas the estimation was 3.61 USD resulting in a +1.24% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Abbvie revenue for the last year?▼
Abbvie revenue for the last year amounts to 61.16B USD.
What is Abbvie net income for the last year?▼
ABBV net income for the last year is 4.23B USD.
Does Abbvie pay dividends?▼
Yes, ABBV dividends are paid quarterly. The last dividend per share was 1.73 USD. As of today, Dividend Yield (FWD)% is 2.7%.
How many employees does Abbvie have?▼
As of September 05, 2026, the company has 57,000 employees.
In which sector is Abbvie located?▼
Abbvie operates in the Health & Wellness sector.
When did Abbvie complete a stock split?▼
Abbvie has not had any recent stock splits.
Where is Abbvie headquartered?▼
Abbvie is headquartered in NORTH CHICAGO, United States.